Clinical Endocrinology
Clinical Endocrinology
5 years ago

TERT promoter hypermethylation is associated with metastatic disease in abdominal paraganglioma

Omid Fotouhi, Johan O. Paulsson, Adam Stenman, Fredrika Svahn, Jan Zedenius, C. Christofer Juhlin, Catharina Larsson
Telomere maintenance, a hallmark of cancer for cell immortalization, is commonly achieved by telomerase activation through induction of the telomerase reverse transcriptase (TERT) gene. Pheochromocytomas (PCC) and abdominal paragangliomas (PGL) (together PPGL) are endocrine tumours for which TERT promoter mutations and telomerase activation have been previously reported [1]. Only 10-15% of PPGL metastasize, however in the absence of metastases, the identification of malignant disease is a diagnostic dilemma. Over 30% of PPGL exhibit a constitutional mutation in one of 14 susceptibility genes, and additionally, recurrent somatic mutations occur frequently [2]. Mutations in VHL, SDHx and EPAS1 define the Cluster 1 mRNA expression profile with pseudo-hypoxic effects, and mutations in HRAS, MAX, NF1, RET and TMEM127 define Cluster 2 with activation of kinase-signaling pathways [2]. This article is protected by copyright. All rights reserved.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/cen.13513

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.